TopoTarget A/S Release: Final Results From CLN-14 Study In STS

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Topotarget announces the final results from the first stage of the phase II part of the phase I/II clinical trial of belinostat in combination with doxorubicin in patients with soft tissue sarcomas (STS) (PXD101-CLN-14).

Help employers find you! Check out all the jobs and post your resume.

Back to news